Replies to post #143286 on Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

The 5-point Investigator's Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials.

http://www.ncbi.nlm.nih.gov/pubmed/24354461

It covers all lesions on the body and that's what caused the confusion for some after reading the interview.



http://www.psoriasis360.com/severe-psoriasis
Pics show mild, moderate and severe:


The Prurisol ph II psoriasis trial protocol looks at both IGA score reduction AND targets lesions.

See more here:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=121463870








In Reply to 'Jhawker'
It seems to me that if the P study didn't identify a specific lesion of a particular grade on each patient then they could literally search the patients body for a spot that cleared up and say that P worked.